Emerald

Private

LondonHealthcare & Life Scienceshttps://withemerald.com/

Last Round

Pre Seed

Jan 29, 2026

Total Funding Raised

$2.86M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Emerald is a healthtech company that provides a preventive health platform integrating diagnostic blood testing, AI-driven analysis, and virtual GP consultations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

preventive healthbiomarker testinglongevitybiohackinghealth membershiptelemedicinewearable dataprecision medicineemployee health benefitsdigital healthhealth optimizationblood screeninghealth analyticsconcierge medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emerald Comps

Public and private peers based on sector, stage, and business model.

Emerald comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Emerald Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Jan 29, 2026
Angel	May 14, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Anton Shchipanov

Co-Founder, CTO

Founding Team

Dan McNally

Co-Founder, Chief Medical Officer

Founding Team

Alexander Badalyan

Co-Founder, CEO

Founding Team

Emerald Investors

Notable investors and investment history

Emerald investors
Investor	Rounds
Granatus Ventures	Pre Seed
Scientia Ventures	Angel
Boost Capital Partners	Pre Seed
Leafy Tunnel	Angel
Boost Capital Partners	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 18, 2026
Monthly visitors increased 153% MoM, reaching 9.1K.
Feb 23, 2026
Grew 24% QoQ, from 17 to 21 employees.

View all signals

Emerald Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Emerald Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Emerald's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range23

Year Founded2025

Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.